© 2023 The American Journal of Medicine Blog. All Rights Reserved.
Pharmaceutical Industry
What's New from AJM
Why California’s Proposition 61 Was a Bad Idea
New approaches to control state pharmaceutical costs are needed.1Â This issue is particularly critical in California, the state with the largest pharmaceutical expenditures in the country.1Â A controversial California ballot initiative aimed at reining in prescription drug expenditures was defeated on November 8, 2016 by a 54% to 46% margin.2The California Drug Price Relief Act, also known as Proposition 61, sought...